Patent details

EP3795592 Title: OPTIMIZATION OF ANTIBODIES THAT BIND LYMPHOCYTE ACTIVATION GENE-3 (LAG-3), AND USES THEREOF

Basic Information

Publication number:
EP3795592
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP201921459
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
OPTIMIZATION OF ANTIBODIES THAT BIND LYMPHOCYTE ACTIVATION GENE-3 (LAG-3), AND USES THEREOF
French Title of Invention:
OPTIMISATION DES ANTICORPS SE LIANT À L'ACTIVATION DES LYMPHOCYTES GÈNE-3 (LAG-3) ET LEURS UTILISATIONS
German Title of Invention:
OPTIMIERUNG VON ANTIKÖRPERN ZUR BINDUNG DES LYMPHOZYTENAKTIVIERUNGSGENS 3 (LAG-3) UND VERWENDUNGEN DAVON
SPC Number:

Dates

Filing date:
02/07/2013
Grant date:
24/07/2024
EP Publication Date:
24/03/2021
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
24/07/2024
EP B1 Publication Date:
24/07/2024
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
02/07/2033
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
17/07/2024
 
 

Name:
Bristol-Myers Squibb Company
Address:
Route 206 and Province Line Road, Princeton, NJ 08543, United States (US)

Agent

Name:
MARKS & CLERK LLP
From:
01/08/2024
Address:
BP 1775, 1017, LUXEMBOURG, Luxembourg (LU)
To:

Inventor

1

Name:
LONBERG, Nils
Address:
United States (US)

2

Name:
SRINIVASAN, Mohan
Address:
United States (US)

Priority

Priority Number:
201261667058 P
Priority Date:
02/07/2012
Priority Country:
United States (US)

Classification

IPC classification:
A61K 45/06; A61P 31/12; A61P 35/00; A61P 37/02; A61P 37/04; C07K 16/28;

Publication

European Patent Bulletin

1

Issue number:
202430
Publication date:
24/07/2024
Description:
Grant (B1)

2

Issue number:
202434
Publication date:
21/08/2024
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
31/07/2025
Annual Fee Number:
13
Annual Fee Amount:
180 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
01/08/2024 Power Of Attorney 1
07/08/2024 Outgoing Correspondence 1